ERBB2 and breast carcinoma: Previous studies have linked DARPP‐32 and HER2‐positive breast cancer; our current findings provide further evidence that the DARPP‐32 signalling nexus plays a role in breast cancer subgroups, in particular, in ER‐positive disease.